Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term human. Found 31 abstracts

no pagination
Holt K, Ye M, Nagar S, Korzekwa KR. Prediction of tissue - plasma partition coefficients using microsomal partitioning: Incorporation into physiologically-based pharmacokinetic models and steady state volume of distribution predictions. Drug metabolism and disposition: the biological fate of chemicals. 2019 Oct;47(10):1050-60.   PMCID: PMC6750188
Arosarena OA, Barr EW, Thorpe R, Yankey H, Tarr JT, Safadi FF. Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases. Journal of cellular physiology. 2018 Jan;233(1):409-21.   PMCID: PMC5592128
Liao L, Liu ZZ, Langbein L, Cai W, Cho EA, Na J, Niu X, Jiang W, Zhong Z, Cai WL, Jagannathan G, Dulaimi E, Testa JR, Uzzo RG, Wang Y, Stark GR, Sun J, Peiper S, Xu Y, Yan Q, Yang H. Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer. eLife. 2018 Oct 25;7.   PMCID: PMC6234029
Franco-Barraza J, Francescone R, Luong T, Shah N, Madhani R, Cukierman G, Dulaimi E, Devarajan K, Egleston BL, Nicolas E, Katherine Alpaugh R, Malik R, Uzzo RG, Hoffman JP, Golemis EA, Cukierman E. Matrix-regulated integrin alphavbeta5 maintains alpha5beta1-dependent desmoplastic traits prognostic of neoplastic recurrence. eLife. 2017 Jan 31;6.   PMCID: PMC5283834
Franco-Barraza J, Francescone R, Luong T, Shah N, Madhani R, Cukierman G, Dulaimi E, Devarajan K, Egleston BL, Nicolas E, Katherine Alpaugh R, Malik R, Uzzo RG, Hoffman JP, Golemis EA, Cukierman E. Matrix-regulated integrin alphavbeta5 maintains alpha5beta1-dependent desmoplastic traits prognostic of neoplastic recurrence. eLife. 2017 Jan 31;6.
Kent T, Mateos-Gomez PA, Sfeir A, Pomerantz RT. Polymerase theta is a robust terminal transferase that oscillates between three different mechanisms during end-joining. eLife. 2016 Jun 17;5.   PMCID: PMC4912351
Ito T, Melamed J, Perle MA, Alukal J. Clear cell sarcoma of the penis: a case report. Am J Clin Exp Urol. 2015 Jan;3(1):43-7.   PMCID: PMC4446382
Motzer RJ, Agarwal N, Beard C, Bhayani S, Bolger GB, Buyyounouski MK, Carducci MA, Chang SS, Choueiri TK, Gupta S, Hancock SL, Hudes GR, Jonasch E, Kuzel TM, Lau C, Levine EG, Lin DW, Margolin KA, Michaelson MD, Olencki T, Pili R, Ratliff TW, Redman BG, Robertson CN, Ryan CJ, Sheinfeld J, Wang J, Wilder RB. Testicular Cancer Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2012 Apr;10(4):502-35.   PMCID: not NIH funded
Shatalova EG, Loginov VI, Bragar EA, Kazubskaja TP, Sudomoina MA, Blanchard RL, Favorova OO. Association of polymorphisms in SULTIAI and UGTIAI genes with breast cancer risk and phenotypes in Russian women. MOLECULAR BIOLOGY. 2006 Mar;40(2):263-70.
Tapiero H, Tew KD. Trace elements in human physiology and pathology: zinc and metallothioneins. Biomedicine & Pharmacotherapy. 2003 Nov;57(9):399-411.
Agus DB, Bunn PA, Franklin W, Garcia M, Ozols RF. HER-2/neu as a therapeutic target in non-small cell lung cancer, prostate cancer, and ovarian cancer. Seminars in Oncology. 2000 Dec;27(6):53-63.
Da Silva I, Hu YF, Russo IH, Ao X, Salicioni AM, Yang XQ, Russo J. S100P calcium-binding protein overexpression is associated with immortalization of human breast epithelial cells in vitro and early stages of breast cancer development in vivo. International Journal of Oncology. 2000 Feb;16(2):231-40.
Lozano F, Simarro M, Calvo J, Vila JM, Padilla O, Bowen MA, Campbell KS. CD5 signal transduction: Positive or negative modulation of antigen receptor signaling. Critical reviews in immunology. 2000 Jan;20(4):347-58.
Barbisan LF, Mello ML, Russo J, Vidal BD. Apoptosis and catastrophic cell death in benzo a pyrene- transformed human breast epithelial cells. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis. 1999 Dec 16;431(1):133-9.
Lee WC, Testa JR. Somatic genetic alterations in human malignant mesothelioma (Review). International Journal of Oncology. 1999 Jan;14(1):181-8.
Loudon RP. Leukocyte chemoattractant chemokine receptors. Drug News & Perspectives. 1999 Apr;12(3):147-56.
Miknyoczki SJ, Lang D, Huang LY, Klein-Szanto AJ, Dionne CA, Ruggeri BA. Neurotrophins and Trk receptors in human pancreatic ductal adenocarcinoma: Expression patterns and effects on in vitro invasive behavior. International journal of cancer. 1999 May 05;81(3):417-27.
Pui JC, Allman D, Xu LW, DeRocco S, Karnell FG, Bakkour S, Lee JY, Kadesch T, Hardy RR, Aster JC, Pear WS. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity. 1999 Sep;11(3):299-308.
Srivastava P, Russo J, Mgbonyebi OP, Russo IH. Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells. Anticancer research. 1998 Nov;18(6A):4003-10.
Tapiero H, Gate L, Dhalluin S, Ba GN, Soupramanien V, Kouyate J, Tew KD. The antioxidant effects of Crassostrea gigas extract (JCOE) in human volunteers. In Vivo. 1998 May;12(3):305-9.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term human

human mouse extracellular matrix cancer biology human biology chromosomes c-myc medicine cancer-associated fibroblasts desmoplasia alphavbeta5 integrin alpha5beta1 integrin breast cancer myofibroblasts apoptosis pancreatic ductal adenocarcinoma in-situ hybridization ERYTHROCYTE-MEMBRANES alpha-fetoprotein kaposis-sarcoma transcription factor bsap DNA repair RAT-LIVER cisplatin antioxidant critical region Secreted Matrix Metalloproteinases molecular-cloning bcl-2 proliferation clinical RICH INTESTINAL PROTEIN genetic instability nonseminoma cisplatin-based chemotherapy Cell Movement activation GENE-EXPRESSION breast epithelial cells diphospho-glucuronosyltransferase 1a1 genotype bilateral acoustic neurofibromatosis testicular cancer ugt1a1 promoter membrane glycoprotein Tumor Cell Line marrow plasma Messenger RNA germ-cell tumors prostatic adenocarcinoma indiana-university experience monoclonal- death chemical carcinogens signal transduction gemcitabine genes ALZHEIMERS-DISEASE BRAIN UDP-glucuronosyltransferase 1A1 taurine hCG multiple regions Membrane Glycoproteins multivariate-analysis Head and Neck Neoplasms CD6 NF2 GROWTH-INHIBITORY FACTOR growth peptide receptor lactate dehydrogenase protein-kinase-c phenol sulfotransferases hiv-1 infection hela-cells Enzymologic Gene Expression Regulation KeyWords Plus: mammalian notch RNA Interference matrix metalloproteinases c-Ha-ras phosphatidylinositol 3-kinase xenograft models sult1a1 Biochemistry & Molecular Biology tumor-suppressor gene genetic diversity gene homozygous deletions kinase family kinase-c HY The authors declare that no competing interests exist factor binding PBPK chromosome abnormalities 2010 ung pw-j clin oncol-v28 lung-cancer salvage chemotherapy gene polymorphism metabolism epithelial cells human bilirubin microhomology-mediated end-joining programmed cell heparan-sulfate NCCN Guidelines endonuclease s-100 protein down-regulation sulfotransferase 1A1 2011 ung p-j natl cancer i-v103-p194 DNA polymerase seminoma poor-prognosis nerve growth-factor UGTIAI pleural mesothelioma neoplasm invasion mouse lymphocytes-t high-dose NCCN Clinical Practice Guidelines factor-like protein protease breast epithelium clear cell placenta sulfation estrogen carcinogenesis 2002 ung p-can j urol-v9-p1637 ankyrin repeats modeling and simulation split complex genes alternative end-Joining positron-emission-tomography tyrosine kinase glutathione-associated enzymes liver pathology ced-3 neoplasms hypotaurine gene amplification status in vitro-in vivo prediction (IVIVE) transformation udp-glucuronosyltransferase extracellular-matrix cancer prevention
Last updated on Thursday, April 02, 2020